Predictmedix Inc said it has entered into a strategic partnership with Paras TechCare, a division of Paras Defence & Space Technologies Ltd (Paras), under which Paras will manufacture, market, sell and distribute Predictmedix's proprietary Safe Entry Stations in a turnkey manner for deployment in the public sector throughout India.
Under the terms of the new reseller agreement, Paras TechCare will manufacture and sell Safe Entry Stations within the southern Asian market on behalf of Predictmedix, where Paras maintains significant public sector relationships through its defense contractor business lines.
“Allowing Paras TechCare to fabricate our platform in India will utilize their engineering expertise to help decrease production time, control costs and increase efficiencies,” Predictmedix chief operating officer Rahul Kushwah said in a statement.
READ: Predictmedix deploys four Safe Entry Stations for upcoming Palm Tree Music Festival in New York
“We are eager to leverage their established relationships in the government, targeting key public sector opportunities where our safety solution can add the most value,” Kushwah added.
Paras Defence director Anish Mehta also commented, stating: “Predictmedix has been an ideal partner, offering incredible rapid health screening solutions that are becoming increasingly prominent within the Indian market. With screening applications from COVID-19 to impairment by drugs or alcohol, we see significant potential for this technology within the Indian public sector.”
Predictmedix noted that Paras is an approved registered vendor to almost all government and public sector departments throughout India and is one of the largest providers of defense-related technologies to the Indian government, with clientele extending into other Asian and Middle Eastern countries.
It added that Paras has secured two initial high-visibility placements at Tier-1 events in India, which is expected to serve as a launching point for near-term commercial awareness of Safe Entry Stations in the country.
Predictmedix’s Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as coronavirus (COVID-19), impairment by drugs or alcohol, or various mental illnesses.
Contact Sean at sean@proactiveinvestors.com